Apixaban/rivaroxabanLack of efficacy and non major bleeding: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1889卷 / 1期

关键词：

D O I：

10.1007/s40278-022-08738-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：59 / 59

相关论文

共 50 条

[1] Apixaban/rivaroxabanLack of efficacy: 2 case reports
[J]. Reactions Weekly, 2023, 1979 (1) : 61 - 61
[2] Apixaban/rivaroxabanLack of efficacy: case report
[J]. Reactions Weekly, 2022, 1934 (1) : 78 - 78
[3] Apixaban/RivaroxabanLack of efficacy
[J]. Reactions Weekly, 2024, 2011 (1) : 59 - 59
[4] Heparin/rivaroxabanLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2023, 1980 (1) : 205 - 205
[5] Apixaban/thalidomideRash and major bleeding : 2 case reports
[J]. Reactions Weekly, 2019, 1750 (1) : 49 - 49
[6] RivaroxabanLack of efficacy: 2 case reports
[J]. Reactions Weekly, 2023, 1949 (1) : 376 - 376
[7] RivaroxabanLack of efficacy: 2 case reports
[J]. Reactions Weekly, 2023, 1943 (1) : 589 - 589
[8] RivaroxabanLack of efficacy: 4 case reports
[J]. Reactions Weekly, 2022, 1889 (1) : 282 - 282
[9] Apixaban/rivaroxabanGI bleeding, retroperitoneal bleeding and lack of efficacy: 4 case reports
[J]. Reactions Weekly, 2019, 1735 (1) : 44 - 44
[10] Apixaban/rivaroxabanGastrointestinal tumour bleeding: 3 case reports
[J]. Reactions Weekly, 2017, 1658 (1) : 49 - 49

← 1 2 3 4 5 →